An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses
Ferran Tarrés-Freixas(IrsiCaixa), Julià Blanco(IrsiCaixa)
Cited by 34
Related Papers
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelope
|The EMBO Journal|2002|147
Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1
|Journal of Antimicrobial Chemotherapy|2015|65
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
|Viruses|2021|20
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity
|International Journal of Molecular Sciences|2023|11